The GMR Clinical Trials Unit is currently recruiting for the following clinical trials in respiratory illness:
protocol: mkc-ci-002 (PI: dr rachel thomson)
Protocol Title: ICoN-1: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Efficacy and Safety of Clofazimine Inhalation Suspension When Added to Guideline-Based Therapy in Participants with Nontuberculous Mycobacterial Infection.
Lay Title: This clinical trial is designed to compare the efficacy and safety of Clofazimine Inhalation Suspension versus placebo when added to guideline-based therapy (GBT) in participants With Nontuberculous Mycobacterial Infection.
Click here for more information
Protocol: IM027-1015 (PI: Dr Katherine semple)
Protocol Title: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Lay Title: The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.
Click here for more information
PROTOCOL: IM027-068 (PI: Dr Katherine Semple)
Protocol Title: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
Lay Title: A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
Click here for more information